Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tocotrienol-Enriched Palm Oil for Hypercholesterolemia
NCT02634606Phase 3Terminated
- Sponsor
- University of California, Los Angeles
- Start
- Mar 2011
- Primary completion
- Nov 2015
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial (3 arms), sponsored by University of California, Los Angeles. Primary endpoint: Change in LDL Cholesterol Over Time Between the 3 Groups at 12 weeks. Started Mar 2011; status: terminated.
Beyond the preview
Go deeper on NCT02634606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02634606.